Here, we observed that in vivo administration of PGRN to wild-type mice with CCl4-induced liver injury or MCD diet-induced NASH significantly reduced inflammation and fibrosis, reflecting a beneficial role for PGRN in chronic liver injury. The gene discussed is GRN; the disease is metabolic dysfunction-associated steatohepatitis.